Dimenhydrinate and Renflexis drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Dimenhydrinate (dimenhydrinate) and Renflexis (infliximab-abda). Common drug interactions include dizziness among females and infusion site erythema among males.

The phase IV clinical study analyzes what interactions people have when they take Dimenhydrinate and Renflexis. It is created by eHealthMe based on reports of 11 people who take the same drugs from the FDA, and is updated regularly.

What is Dimenhydrinate?

Dimenhydrinate has active ingredients of dimenhydrinate. It is often used in nausea. eHealthMe is studying from 6,644 Dimenhydrinate users. Check the latest studies of Dimenhydrinate.

What is Renflexis?

Renflexis has active ingredients of infliximab-abda. eHealthMe is studying from 1,316 Renflexis users. Check the latest studies of Renflexis.

On Jul, 11, 2026

11 people who take Dimenhydrinate and Renflexis together, and have interactions are studied.

Dimenhydrinate and Renflexis drug interactions.

What are the common drug interactions of Dimenhydrinate and Renflexis, by gender? *:

female:

Dizziness
Drug ineffective
Flushing (the warm, red condition of human skin)
Hypotension (abnormally low blood pressure)
Pallor
Scleral hyperaemia (excess blood supply to sclera)
Screaming (a long loud piercing cry)
Crohn's disease (a condition that causes inflammation of the gastrointestinal tract)
Malaise (a feeling of general discomfort or uneasiness)
Sleep disorder

male:

Infusion site erythema (reddening of the skin at infusion site)
Infusion site rash
Somnolence (a state of near-sleep, a strong desire for sleep)
Weight decreased

What are the common drug interactions of Dimenhydrinate and Renflexis, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

Colitis ulcerative (inflammation of colon with ulcer)
Maternal exposure during pregnancy (use of substance during pregnancy)
Somnolence (a state of near-sleep, a strong desire for sleep)

40-49:

Pallor
Scleral hyperaemia (excess blood supply to sclera)
Screaming (a long loud piercing cry)
Anxiety
Cold sweat
Infusion site erythema (reddening of the skin at infusion site)
Infusion site rash
Somnolence (a state of near-sleep, a strong desire for sleep)
Weight decreased
Abdominal pain

50-59:

Crohn's disease (a condition that causes inflammation of the gastrointestinal tract)
Malaise (a feeling of general discomfort or uneasiness)
Sleep disorder

60+:

n/a

What are the existing conditions these people have? *

Ulcerative Colitis (inflammatory bowel disease (ibd). it causes swelling, ulcerations, and loss of function of the large intestine): 10 people, 90.91%
Heart Attack: 1 person, 9.09%
Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 1 person, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Dimenhydrinate and Renflexis?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously